Literature DB >> 9166017

Paediatric HIV infection.

M Sharland1, D Gibb, G Tudor-Williams, S Walters, V Novelli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9166017      PMCID： PMC1717137          DOI： 10.1136/adc.76.4.293

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  23 in total

1.  Physicians' experience with the acquired immunodeficiency syndrome as a factor in patients' survival.

Authors:  M M Kitahata; T D Koepsell; R A Deyo; C L Maxwell; W T Dodge; E H Wagner
Journal:  N Engl J Med       Date:  1996-03-14       Impact factor: 91.245

2.  Managing HIV disease after Delta.

Authors:  A J Pinching
Journal:  BMJ       Date:  1996-03-02

3.  HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time.

Authors:  A S Perelson; A U Neumann; M Markowitz; J M Leonard; D D Ho
Journal:  Science       Date:  1996-03-15       Impact factor: 47.728

4.  Encephalopathy in children with perinatally acquired human immunodeficiency virus infection. Pediatric Spectrum of Disease Clinical Consortium.

Authors:  M N Lobato; M B Caldwell; P Ng; M J Oxtoby
Journal:  J Pediatr       Date:  1995-05       Impact factor: 4.406

5.  Birth order, delivery route, and concordance in the transmission of human immunodeficiency virus type 1 from mothers to twins. International Registry of HIV-Exposed Twins.

Authors:  A M Duliège; C I Amos; S Felton; R J Biggar; J J Goedert
Journal:  J Pediatr       Date:  1995-04       Impact factor: 4.406

6.  Older children and adolescents living with perinatally acquired human immunodeficiency virus infection.

Authors:  S Grubman; E Gross; N Lerner-Weiss; M Hernandez; G D McSherry; L G Hoyt; M Boland; J M Oleske
Journal:  Pediatrics       Date:  1995-05       Impact factor: 7.124

7.  Influence of host genotype on progression to acquired immunodeficiency syndrome among children infected with human immunodeficiency virus type 1.

Authors:  J J Just; E Abrams; L G Louie; R Urbano; D Wara; S W Nicholas; Z Stein; M C King
Journal:  J Pediatr       Date:  1995-10       Impact factor: 4.406

8.  Energy expenditure and wasting in human immunodeficiency virus infection.

Authors:  D C Macallan; C Noble; C Baldwin; S A Jebb; A M Prentice; W A Coward; M B Sawyer; T J McManus; G E Griffin
Journal:  N Engl J Med       Date:  1995-07-13       Impact factor: 91.245

9.  Shortened survival in infants vertically infected with human immunodeficiency virus with elevated p24 antigenemia.

Authors:  N Z Arlievsky; H Pollack; M Rigaud; A Kaul; K Krasinski; W Borkowsky
Journal:  J Pediatr       Date:  1995-10       Impact factor: 4.406

10.  How much paediatric HIV infection could be prevented by antenatal HIV testing?

Authors:  D T Dunn; A Nicoll; F J Holland; C F Davison
Journal:  J Med Screen       Date:  1995       Impact factor: 2.136
View more
  3 in total

1.  Advances in the prevention and treatment of paediatric HIV infection in the United Kingdom.

Authors:  M Sharland; D M Gibb; G Tudor-Williams
Journal:  Arch Dis Child       Date:  2002-09       Impact factor: 3.791

Review 2.  Advances in the prevention and treatment of paediatric HIV infection in the United Kingdom.

Authors:  M Sharland; D M Gibb; G Tudor-Williams
Journal:  Sex Transm Infect       Date:  2003-02       Impact factor: 3.519

3.  The needs of children whose mothers have HIV infection.

Authors:  J Mok; S Cooper
Journal:  Arch Dis Child       Date:  1997-12       Impact factor: 3.791
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.